Research programme: monoclonal antibodies - CPL Biologicals
Alternative Names: Monoclonal antibodies - CPL BiologicalsLatest Information Update: 02 Sep 2024
Price :
$50 *
At a glance
- Originator CPL Biologicals
- Class Immunoglobulins; Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified
Most Recent Events
- 02 Sep 2024 Monoclonal antibodies are still in early research for an unknown indication in India (CPL Biologicals pipeline, September 2024)
- 28 Feb 2024 No recent reports of development identified for research development in Unspecified in India
- 02 Jan 2020 Early research in Unspecified in India (unspecified route) (CPL Biologicals website, January 2020)